-
2016[Pertussis: Where do we stand 10years after the introduction of cocooning vaccination strategy in France?], Gynecol Obstet Fertil 2016 Sep;.
-
2016Surveillance of pertussis: methods and implementation, Expert Rev Anti Infect Ther 2016 Jul;14(7):657-67.
-
2015Opportunistic Pulmonary Bordetella hinzii Infection after Avian Exposure, Emerging Infect. Dis. 2015 Dec;21(12):2122-6.
-
2015New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates, Vaccines (Basel) 2015;3(3):751-70.
-
2015Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough, Pathog Dis 2015 Oct;73(7).
-
2015Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years’ Experience, 1996-2012, France, Pediatr. Infect. Dis. J. 2015 Aug;34(8):814-20.
-
2015Draft Genome Sequences of Two Species of “Difficult-to-Identify” Human-Pathogenic Corynebacteria: Implications for Better Identification Tests, J Genomics 2015;3:82-4.
-
2015Structure activity characterization of Bordetella petrii lipid A, from environment to human isolates, Biochimie 2016 Jan;120:87-95.
-
2015Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype, J. Cyst. Fibros. 2015 Sep;14(5):E13-5.
-
2015Genome Sequence of Corynebacterium ulcerans Strain FRC11, Genome Announc 2015 Mar;3(2).
-
2014Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine, Vaccine 2014 Nov;32(49):6597-600.
-
2014Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland, Arch. Immunol. Ther. Exp. (Warsz.) 2015 Apr;63(2):155-60.
-
2014Other Bordetellas, lessons for and from pertussis vaccines, Expert Rev Vaccines 2014 Sep;13(9):1125-33.
-
2014Pertussis vaccination and whooping cough: and now what?, Expert Rev Vaccines 2014 Oct;13(10):1163-5.
-
2014Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines, Expert Rev Vaccines 2014 Sep;13(9):1135-46.
-
2014Global population structure and evolution of Bordetella pertussis and their relationship with vaccination, MBio 2014;5(2):e01074.
-
2014Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia, Emerging Infect. Dis. 2014 Apr;20(4):626-33.
-
2014Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population, Microbiology (Reading, Engl.) 2014 May;160(Pt 5):962-9.
-
2014Draft Genome Sequence of Corynebacterium ulcerans FRC58, Isolated from the Bronchitic Aspiration of a Patient in France, Genome Announc 2014 Jan;2(1).
-
2013New diphtheria toxin repressor types depicted in a Romanian collection of Corynebacterium diphtheriae isolates, J. Basic Microbiol. 2014 Oct;54(10):1136-9.
-
2013Epidemiology of whooping cough & typing of Bordetella pertussis, Future Microbiol 2013 Nov;8(11):1391-403.
-
2013Bordetella pertussis: why is it still circulating?, J. Infect. 2014 Jan;68 Suppl 1:S119-24.
-
2013Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab, Emerging Infect. Dis. 2013 Oct;19(10):1703-5.
-
2013Bordetella holmesii and pertussis diagnosis, Pathology 2013 Aug;45(5):531-2.
-
2013How to fight pertussis?, Ther Adv Vaccines 2013 Jul;1(2):59-66.
-
2013Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era, Carbohydr. Res. 2013 Aug;378:56-62.
-
2013In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Microbes Infect. 2013 May;15(5):399-408.
-
2013Virulence of pertactin-negative Bordetella pertussis isolates from infants, France, Emerging Infect. Dis. 2013 Mar;19(3):471-4.
-
2012Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009, J. Clin. Microbiol. 2013 Feb;51(2):422-8.
-
2012Specific biological diagnoses are needed to determine the durability of pertussis vaccine-induced immunity, Clin. Infect. Dis. 2012 Nov;55(10):1433-4; author reply 1435-6.
-
2012Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin, Clin. Microbiol. Infect. 2012 Sep;18(9):E340-6.
-
2012Macrolide-resistant Bordetella pertussis infection in newborn girl, France, Emerging Infect. Dis. 2012 Jun;18(6):966-8.
-
2012Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study, Diagn. Microbiol. Infect. Dis. 2012 Apr;72(4):303-17.
-
2011Antimicrobial drug resistance in Corynebacterium diphtheriae mitis, Emerging Infect. Dis. 2011 Nov;17(11):2078-80.
-
2011Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis, J. Clin. Microbiol. 2011 Dec;49(12):4347-8.
-
2011Septic arthritis caused by Bordetella holmesii in an adolescent with chronic haemolytic anaemia, J. Med. Microbiol. 2011 Nov;60(Pt 11):1705-7.
-
2011Rationale for pertussis booster vaccination throughout life in Europe, Lancet Infect Dis 2011 Jul;11(7):557-70.
-
2011Diphtheria in the south of France, March 2011, Euro Surveill. 2011;16(19).
-
2011Bordetella petrii infection with long-lasting persistence in human, Emerging Infect. Dis. 2011 Apr;17(4):612-8.
-
2011The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010, Hum Vaccin 2011 Apr;7(4):481-8.
-
2011Structural modifications occurring in lipid A of Bordetella bronchiseptica clinical isolates as demonstrated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom. 2011 Apr;25(8):1075-81.
-
2011Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009, Euro Surveill. 2011;16(5).
-
2010The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence, BMC Genomics 2010;11:728.
-
2010The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010, Vaccine 2011 Feb;29(6):1115-21.
-
2010What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories, Eur. J. Clin. Microbiol. Infect. Dis. 2011 Mar;30(3):307-12.
-
2010Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history, Hum Vaccin 2010 Oct;6(10):829-34.
-
2010Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009, Res. Microbiol. 2010 Dec;161(10):810-5.
-
2010Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii, J. Clin. Microbiol. 2010 Oct;48(10):3762-4.
-
2010Pertussis prevention and diagnosis practices for adolescents and adults among a national sample of French general practitioners, Prev Med 2010 Jul;51(1):90-1.
-
2010Vaccination in older adults: development of an educational tool, Vaxisenior, in France, Expert Rev Vaccines 2010 Mar;9(3 Suppl):15-20.
-
2010Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host, Biochimie 2010 Jun;92(6):583-7.
-
2009Bordetella pertussis and pertussis vaccines, Clin. Infect. Dis. 2009 Nov;49(10):1565-9.
-
2009Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses, J. Clin. Microbiol. 2009 Oct;47(10):3197-203.
-
2009First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin, Vaccine 2009 Oct;27(43):6034-41.
-
2009Educational vaccine tools: the French initiative, Aging Clin Exp Res 2009 Jun;21(3):250-3.
-
2009Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations, Hum Vaccin 2009 May;5(5):341-6.
-
2009Diphtheria: a zoonotic disease in France?, Vaccine 2009 Jun;27(31):4196-200.
-
2009Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial, Hum Vaccin 2009 May;5(5):315-21.
-
2009Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Res. Microbiol. 2009 Jun;160(5):330-6.
-
2009Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa, Clin. Vaccine Immunol. 2009 Apr;16(4):479-83.
-
2008Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas, Microbes Infect. 2008 Nov-Dec;10(14-15):1582-6.
-
2008[Whooping cough from infants to adults], Bull. Acad. Natl. Med. 2008 Oct;192(7):1437-49; discussion 1449-52.
-
2008Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis, J. Clin. Microbiol. 2008 Nov;46(11):3636-8.
-
2008Assessment of individual vaccine status in a vaccinology experts’ group, J Eval Clin Pract 2008 Aug;14(4):610-4.
-
2008Pertussis surveillance in private pediatric practices, France, 2002-2006, Emerging Infect. Dis. 2008 Jul;14(7):1159-61.
-
2008Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination, PLoS ONE 2008;3(6):e2437.
-
2008Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?, J. Clin. Microbiol. 2008 Jun;46(6):2125-8.
-
2008Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007, J. Clin. Microbiol. 2008 May;46(5):1672-7.
-
2008Bordetella pertussis polymorphism and pertussis vaccines, Clin. Vaccine Immunol. 2008 Feb;15(2):394; author reply 394-5.
-
2007Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis, J. Clin. Microbiol. 2007 Oct;45(10):3257-62.
-
2007[Impact of vaccination on the infectious diseases epidemiology: example of pertussis], Med Sci (Paris) 2007 Apr;23(4):399-403.
-
2007Transmission of Bordetella pertussis to young infants, Pediatr. Infect. Dis. J. 2007 Apr;26(4):293-9.
-
2006Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life, Vaccine 2007 Feb;25(8):1390-7.
-
2005Nucleic Acid amplification tests for diagnosis of Bordetella infections, J. Clin. Microbiol. 2005 Oct;43(10):4925-9.
-
2004Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells, Infect. Immun. 2004 Sep;72(9):5530-3.
-
2004Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate, Infect. Immun. 2004 Aug;72(8):4874-7.
-
2003Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract, Infect. Immun. 2003 Jul;71(7):4137-43.
-
2003Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis, Mol. Genet. Genomics 2003 Jul;269(4):475-86.
-
2002Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage, J. Infect. Dis. 2002 Aug;186(3):415-8.
-
2001Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years, J. Clin. Microbiol. 2001 Dec;39(12):4396-403.
-
2001Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity, Cell. Microbiol. 2001 Nov;3(11):721-30.
-
2001The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)., J Exp Med 2001 May; 193(9): 1035-44.
-
2000Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, Infect. Immun. 2000 Aug;68(8):4815-7.
-
2000Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis, Infect. Immun. 2000 Apr;68(4):1934-41.
-
2000Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology, Eur. J. Clin. Microbiol. Infect. Dis. 2000 Mar;19(3):174-81.
-
1999Influence of vaccination coverage on pertussis transmission in France, Lancet 1999 Nov;354(9191):1699-700.
-
1999Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine, Vaccine 1999 Jun;17(20-21):2651-60.
-
1999Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines, Vaccine 1999 May;17(19):2366-76.
-
1998Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination, Pediatr. Infect. Dis. J. 1998 May;17(5):412-8.
-
1998Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal, Clin. Diagn. Lab. Immunol. 1998 Mar;5(2):130-4.
-
1997A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal, Vaccine 1997 Oct;15(15):1606-12.
-
1995Cloning and sequence of the Bordetella bronchiseptica adenylate cyclase-hemolysin-encoding gene: comparison with the Bordetella pertussis gene, Gene 1995 Aug;162(1):165-6.
-
1995Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host, J. Clin. Microbiol. 1995 Aug;33(8):2002-6.
-
1993Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin, Infect. Immun. 1993 Oct;61(10):4072-8.
-
1993Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin, Infect. Immun. 1993 Oct;61(10):4064-71.
-
1993CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin, Infect. Immun. 1993 Sep;61(9):3583-9.
-
1992Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection, Microb. Pathog. 1992 Mar;12(3):227-35.
-
1991Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization, Microb. Pathog. 1991 Dec;11(6):423-31.
-
1989Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen, Microb. Pathog. 1989 Nov;7(5):373-80.
-
1986Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay, J. Biol. Chem. 1986 Dec;261(34):16264-9.